A medical and molecular approach to kefir as a therapeutic agent of human microbiota-A review
Yazarlar (2)
Doç. Dr. Zeynep YEĞİN Sinop Üniversitesi, Türkiye
Mert Sudağıdan
Konya Gida ve Tarim Üniversitesi, Türkiye
Makale Türü Diğer (Teknik, not, yorum, vaka takdimi, editöre mektup, özet, kitap krıtiği, araştırma notu, bilirkişi raporu ve benzeri) (SCI, SSCI, AHCI, SCI-Exp dergilerinde yayınlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden makale)
Dergi Adı International Journal for Vitamin and Nutrition Research (Q3)
Dergi ISSN 0300-9831 Dergi Bilgileri (2024)
Dergi Tarandığı Indeksler SCI
Makale Dili İngilizce Basım Tarihi 02-2024
Kabul Tarihi – Yayınlanma Tarihi 01-02-2024
Cilt / Sayı / Sayfa 94 / 1 / 71–80 DOI 10.1024/0300-9831/a000765
Makale Linki https://econtent.hogrefe.com/doi/10.1024/0300-9831/a000765
UAK Araştırma Alanları
Tıbbi Biyoloji
Özet
The imbalanced microbial composition called dysbiosis constitutes a tendency related to different kind of human diseases. To overcome the disadvantages of dysbiosis, the consumption of probiotics is an emerging and promising topic of the last decade. Kefir is a probiotic fermented beverage produced from the fermentation of kefir grains with changing varieties of milk and displays a symbiotic association of bacteria and yeast. The discovery of the concept that fermented foods/beverages such as kefir could modify gut microbiota in humans has widened the borders of precision medicine and now microbiome therapeutics can be considered as a significant part of this field. Kefir seems to have potential to guide and manipulate future replacement/complementary therapies with a variety of beneficial biological/medical properties it has. The aim of this review was a comprehensive recapitulation of probiotic beverage …
Anahtar Kelimeler
Antitumor | Apoptosis | Kefir | Microbiota | Neuroprotection | Probiotic | Psychobiotic
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Web of Science 7
Scopus 4
Google Scholar 9
A medical and molecular approach to kefir as a therapeutic agent of human microbiota-A review